EFX three-lens brief
Evidence-based stock research on EFX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $220.43 — 30% above current (21 analysts).
- Analyst mean target $220.43 — 30% above current (21 analysts).
- Earnings scheduled 2026-07-21.
EFX closed at $169.89 (+1.94%) as of 2026-07-10. Market cap: $20.49B. P/E (trailing) 29.9. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $220.43 — 30% above current (21 analysts).. Last quarter: Revenue $1.65B, net income $171.50M, free cash flow $1.02B. Watching for: 2026-07-21 earnings release (10 days out).
Why three lenses on EFX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine EFXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/EFX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath EFX brief"></iframe>